Procalcitonin as an Indicator of Antibacterial Therapy in Covid-19

Abstract

The article presents laboratory characteristics as well as the potential of biomarkers to predict disease severity in patients infected with SARS-CoV-2. 120 patients with a new coronavirus infection were examined. All patients had laboratory confirmed SARS-CoV-2 infection. The patients were divided into severe patients (n = 60) and patients with moderate forms (n = 60). The average age was 53 years, of 120 patients 96 (80%) were men. The importance of procalcitonin as a biomarker for assessing the risk of bacterial infection, disease progression, timely administration of antibacterial drugs and the duration of the course of antibacterial therapy was studied.